Watch · Quality 22/100
Simple research view
CVS · CVS Health Corporation
$107.07 latest stored close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$CVS
CVS Health CorporationCVS Health Corporation is a large-cap Drugstore Chains company in the Retail Trade sector with a market cap of $137B.
Council read · 6 methods
Watch — evidence is building
0 buyable · 6 watch · 0 avoid. Review the observed passes and blockers before reading the chart.
Earnings-risk mode
Pre-earnings setup
Thursday, July 30, 2026
Time not confirmed
No sourced report session or clock time
Ordinary position sizing suppressed.
Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.
Deterministic evidence
CVS-0.62%
Broad market · SPY+0.02%
CatalystUnavailable
Stock reactionNegative
Sector reactionUnavailable
Opening surgeUnavailable
Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
AI interpretation (optional)
Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.
Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.CVS Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Setup Quality
B+
5/7 signals
Score trend
✓
Stage 2 · Advancing
✓
Power Trend 30d
✗ RS New High
✓ Trend 8/8
✗
No Pattern
✓ CANSLIM 76.6 (B)
✓ Gatekeeper
Base #2 (B)
Technical Analysis Report Card
$CVS · $107.07 · as of 2026-07-27 · multi-factor read
87
/ 100
Trend · Daily / Weekly / Monthly
Daily
▲ Uptrend
Weekly
▲ Uptrend
Monthly
▲ Uptrend
Moving Averages
50-day$100.27 ↑
100-day$89.28 ↑
200-day$84.00 ↑
Bullish (50 > 200)
RSI (14)
Reading58.9 · Bullish
Bullish momentum — comfortably in buyer territory.
MACD (12/26/9)
StateWeakening
Histogram-0.257
Weakening — MACD slipped below its signal line. Histogram contracting.
Bollinger Bands (20,2)
%B / Width66% · 7.9%
Squeeze — volatility compressing
Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.
Volume · Buyer vs Seller
Up/Down vol1.05 · Neutral
Rel volume0.98×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.
Support & Resistance
R · $110.6852-week high
Price · $107.07now
S · $101.78swing level
S · $89.42swing level
S · $78.22swing level
Fibonacci · Uptrend swing
23.6%$100.96
38.2%$94.95
50.0%$90.09
61.8%$85.24
78.6%$78.32
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for CVS — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 87 (leader)
Want this read in a legend's voice?
💬 Ask a Legend about CVS
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
🟡 6 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B
Trend-template read: 9/12 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $107.07, MA150 $85.67, MA200 $84.00
1.2 150-day MA > 200-day MAMA150 $85.67 vs MA200 $84.00
Failing evidence
2. ROE ≥ 17%ROE 3.9%
2. Revenue growth ≥ 20% YoY+7.8% YoY
Watch
O'Neil D
CANSLIM read: 4/8 pass; improvement is still needed.
Passing evidence
C: Quarterly EPS acceleration ≥ 25%+135.8% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 87
Failing evidence
A: Annual earnings & revenue qualityRev +7.8% | ROE 3.9%
S: Volume ≥ 40% above average on breakoutVolume ratio 0.98x
Watch
Weinstein B
Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $107.07 vs MA200 $84.00
Failing evidence
Volume expansion above averageVolume ratio 0.98x
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$107.07
Relative strengthRS 87
Failing evidence
Volume vs average0.98x
Pivotal point cleared on expanding volumeNot confirmed
Watch
Darvas B
Box-theory read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$107.07
Relative strengthRS 87
Failing evidence
Volume vs average0.98x
Box top broken on heavy volumeNot confirmed
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$107.07
Relative strengthRS 87
Failing evidence
Volume vs average0.98x
Sign of Strength confirmed on expanding volume0.98x average volume — needs ≥1.4x
Breakout Health
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +6
Fundamentals & leadership quality — Minervini SEPA criteria · 4/7 met
B
4/7 SEPA
Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+136%
Revenue growth ≥20% YoY
+8%
Gross margin ≥30%
14%
ROE ≥17%
4%
RS rating ≥80 (leadership)
87
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-3.3%
Method Playbook
📋 Trade it like Weinstein
EXACT LEVELS · PRO
Weinstein B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis
55.0
score
RS Score
87
Trend
8/8 ✓
CANSLIM
76.6* (B)
range low: 72.56
range high: 89.647
range pct: 0.235
sos thrust: 0.188
sos vol ratio: 1.473
sos bars ago: 7
near lps: ✗
validation reason: valid generic setup
multi tf evaluated: ✓
multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS
SOS: breakout above range_high=89.65, thrust=18.8%, vol=1.5x avg, lps=extended, 7 bars ago | Strong trend (8/8) | Top RS (87) | Moderate pattern (63%) | Power Trend | Stage 2 | Readiness 63/100 (early) | CANSLIM 76.6 (B) | ⚠ Extended past buy zone; 3rd-stage base; Not actionable yet
The Universal Edge Check
The panel is uneasy
Too many universals unmet — this leans closer to a guess than a trade.
2/7
universals met
- In a confirmed uptrend Stage 2 · Trend 8/8
- Risk is defined No stop — undefined risk
- Asymmetric reward No target set
- Not chasing (in range) Pivot distance unknown
- Volume confirms 1.0× average — light
- Clear of earnings in 2 days — event risk
- A relative-strength leader RS 90
Minervini Trend Template
8/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$107.07 vs SMA150 $85.67 / SMA200 $84.00
SMA 150 above SMA 200
SMA150 $85.67 vs SMA200 $84.00
SMA 200 trending up
Slope +3.03 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $100.27
Price above SMA 50
$107.07 vs SMA50 $100.27
30%+ above 52W low
+81.5% from $58.99
Within 25% of 52W high
-3.3% from $110.68
RS score above 70
RS 87
Fundamentals
52W Range
93%
Mkt Cap SEC
136.6B
EPS QoQ
+136%
Rev YoY
+8%
ROE
4%
Gross Margin
14%
D/E
0.86
EPS TTM
$1.39
P/E TTM
77.0x
Float
1.3B
Insider
No Buy
Company
Legend AI snapshot
CVS Health Corporation
$107.07latest close
$136.6Bmarket cap
90RS rank
55setup score
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B
76.6* CANSLIM
* disqualified on M
C · Curr. EPS
100
A · Annual EPS
62
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
87
I · Inst. Spons.
96
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
8/8
W. RS
100
W. Support
$69.51
W. Resist
$110.68
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Scan History
20× streakJul 28
Wyckoff SOS
✓ Gate
55
Jul 27
Trend Only
✓ Gate
94
0.0%
Jul 24
Trend Only
✓ Gate
94
-0.6%
Jul 24
Trend Only
✓ Gate
94
-0.6%
Get the full picture on CVS
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.
Start 7-Day Free Trial